Form 4: Lemaitre Vascular Inc. Insider Transaction: Dividend Equivalent Rights Released

Lemaitre Vascular Inc. reports the release of dividend equivalent rights, resulting in the acquisition of common stock by an insider.

Summary

• On December 9, 2024, Lemaitre Vascular Inc. reported the release of dividend equivalent rights.
• These rights were associated with a restricted stock unit award granted on December 8, 2023.
• The release resulted in the acquisition of 1 share of common stock on a one-for-one basis.
• Each dividend equivalent right is economically equivalent to one share of the company's common stock.
• The transaction was reported by John Pitfield on December 11, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine insider transaction related to equity compensation, which is generally neutral to positive. It indicates that the company is following its compensation plan.

Industry Context

This type of transaction is common for companies that use stock-based compensation as part of their employee incentive programs. It reflects the vesting of previously granted equity awards.

Comparison to Industry Standards

• Many companies in the medical device industry use restricted stock units and dividend equivalent rights as part of their compensation packages.
• The one-for-one conversion of dividend equivalent rights to common stock is a standard practice.
• Companies like Medtronic and Boston Scientific also use similar equity-based compensation methods.

Stakeholder Impact

• The transaction has a minor positive impact on the insider receiving the shares.
• The impact on other stakeholders is negligible.

Key Dates

Keywords

dividend equivalent rights, restricted stock unit, insider transaction, common stock, Lemaitre Vascular